Cheng Zhang
Directeur/Membre du Conseil chez Beijing Biostar Pharmaceuticals Co. Ltd.
Postes actifs de Cheng Zhang
Sociétés | Poste | Début | Fin |
---|---|---|---|
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | Directeur/Membre du Conseil | 15/08/2018 | - |
Corporate Officer/Principal | 01/03/2021 | - |
Historique de carrière de Cheng Zhang
Formation de Cheng Zhang
Sichuan University | Graduate Degree |
Statistiques
Internationale
Chine | 3 |
Opérationnelle
Director/Board Member | 1 |
Corporate Officer/Principal | 1 |
Graduate Degree | 1 |
Sectorielle
Health Technology | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | Health Technology |
- Bourse
- Insiders
- Cheng Zhang
- Expérience